Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2009, 77(Posters (PO)), 214; https://doi.org/10.3797/scipharm.oephg.21.PO-15 (registering DOI)
Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives
Institute of Pharmaceutical Sciences, Karl-Franzens-University of Graz, Universitätsplatz 1, 8010 Graz, Austria
Author to whom correspondence should be addressed.
Received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Note: In lieu of an abstract, this is an excerpt from the first page.
Every year about half a million people are infected with Human African Trypanosomiasis (HAT) and more than 40.000 people die from this disease . Infections with Trypanosoma brucei rhodesiense
, which is the more virulent of the two causative organisms, can only be treated with two drugs, suramin and melarsoprol, which can cause severe side effects and which have to be administered by painful injections.[...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
WEIS, R.; FAIST, J.; SEEBACHER, W. Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives. Sci. Pharm. 2009, 77, 214.
WEIS R, FAIST J, SEEBACHER W. Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives. Scientia Pharmaceutica. 2009; 77(Posters (PO)):214.
WEIS, R.; FAIST, J.; SEEBACHER, W. 2009. "Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives." Sci. Pharm. 77, Posters (PO): 214.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.